19 results on '"Raven, Alexander"'
Search Results
2. Impairing hepatocyte regeneration to determine the regenerative capacity of the biliary epithelium
- Author
-
Raven, Alexander Philip, Forbes, Stuart, and Ffrench-Constant, Charles
- Subjects
616.3 ,liver ,regeneration ,liver regeneration ,stem cell - Abstract
Liver injury stimulates hepatocyte proliferation, regenerating the liver through self-replication. In cases where there is severe, repetitive, parenchymal damage, as seen in human chronic liver disease, hepatocyte mediated regeneration becomes impaired. In this setting it is currently unclear whether endogenous biliary epithelial cells can repopulate the hepatocyte compartment. This thesis therefore aimed to address this point by lineage tracing the main two liver epithelia populations on a background of impaired hepatocyte regeneration. To impair regeneration, an Itgb1 transgene was specifically deleted, conditionally, from the hepatocyte epithelium. Long-term loss of β1-Integrin alone or with additional injury caused an epithelial ductular reaction of biliary origin. Alongside β1-Integrin ablation, the hepatocyte epithelium was also labelled with a heritable ROSA26LSLtdTomato reporter. Impaired hepatocyte regeneration mediated by β1- integrin ablation resulted in 25% of hepatocytes becoming tdTomato negative (non-hepatocyte derived). To verify that the non-hepatocyte mediated regeneration was originating from the biliary epithelium, anti-Itgb1 RNAi was administrated to K19CreERT LSLtdTomato mice. Resulting in tdTomato positive hepatocytes that had differentiated from the labelled tdTomato positive biliary epithelial cells. In summary, this thesis demonstrates that hepatocyte β1-Integrin ablation combined with toxic damage causes marked ductular reactions and results in a substantial regeneration of functional hepatocytes from the biliary epithelium.
- Published
- 2018
3. NOTUM from Apc-mutant cells biases clonal competition to initiate cancer
- Author
-
Flanagan, Dustin J., Pentinmikko, Nalle, Luopajärvi, Kalle, Willis, Nicky J., Gilroy, Kathryn, Raven, Alexander P., Mcgarry, Lynn, Englund, Johanna I., Webb, Anna T., Scharaw, Sandra, Nasreddin, Nadia, Hodder, Michael C., Ridgway, Rachel A., Minnee, Emma, Sphyris, Nathalie, Gilchrist, Ella, and Najumudeen, Arafath K.
- Subjects
Gene mutations -- Health aspects ,Stem cells -- Physiological aspects -- Genetic aspects ,Colorectal cancer -- Genetic aspects ,Tumor suppressor genes -- Health aspects ,Environmental issues ,Science and technology ,Zoology and wildlife conservation - Abstract
The tumour suppressor APC is the most commonly mutated gene in colorectal cancer. Loss of Apc in intestinal stem cells drives the formation of adenomas in mice via increased WNT signalling.sup.1, but reduced secretion of WNT ligands increases the ability of Apc-mutant intestinal stem cells to colonize a crypt (known as fixation).sup.2. Here we investigated how Apc-mutant cells gain a clonal advantage over wild-type counterparts to achieve fixation. We found that Apc-mutant cells are enriched for transcripts that encode several secreted WNT antagonists, with Notum being the most highly expressed. Conditioned medium from Apc-mutant cells suppressed the growth of wild-type organoids in a NOTUM-dependent manner. Furthermore, NOTUM-secreting Apc-mutant clones actively inhibited the proliferation of surrounding wild-type crypt cells and drove their differentiation, thereby outcompeting crypt cells from the niche. Genetic or pharmacological inhibition of NOTUM abrogated the ability of Apc-mutant cells to expand and form intestinal adenomas. We identify NOTUM as a key mediator during the early stages of mutation fixation that can be targeted to restore wild-type cell competitiveness and provide preventative strategies for people at a high risk of developing colorectal cancer. NOTUM from Apc-mutant cells acts as a key mediator during the early stages of mutation fixation and drives the formation of intestinal adenomas., Author(s): Dustin J. Flanagan [sup.1] , Nalle Pentinmikko [sup.2] [sup.3] , Kalle Luopajärvi [sup.2] [sup.3] , Nicky J. Willis [sup.4] , Kathryn Gilroy [sup.1] [sup.5] , Alexander P. Raven [sup.1] [...]
- Published
- 2021
- Full Text
- View/download PDF
4. Oncogenic BRAF, unrestrained by TGFβ-receptor signalling, drives right-sided colonic tumorigenesis
- Author
-
Leach, Joshua D. G., Vlahov, Nikola, Tsantoulis, Petros, Ridgway, Rachel A., Flanagan, Dustin J., Gilroy, Kathryn, Sphyris, Nathalie, Vázquez, Ester G., Vincent, David F., Faller, William J., Hodder, Michael C., Raven, Alexander, Fey, Sigrid, Najumudeen, Arafath K., Strathdee, Douglas, Nixon, Colin, Hughes, Mark, Clark, William, Shaw, Robin, van Hooff, Sander R., Huels, David J., Medema, Jan Paul, Barry, Simon T., Frame, Margaret C., Unciti-Broceta, Asier, Leedham, Simon J., Inman, Gareth J., Jackstadt, Rene, Thompson, Barry J., Campbell, Andrew D., Tejpar, Sabine, and Sansom, Owen J.
- Published
- 2021
- Full Text
- View/download PDF
5. Epigenetic remodelling licences adult cholangiocytes for organoid formation and liver regeneration
- Author
-
Aloia, Luigi, McKie, Mikel Alexander, Vernaz, Grégoire, Cordero-Espinoza, Lucía, Aleksieva, Niya, van den Ameele, Jelle, Antonica, Francesco, Font-Cunill, Berta, Raven, Alexander, Aiese Cigliano, Riccardo, Belenguer, German, Mort, Richard L., Brand, Andrea H., Zernicka-Goetz, Magdalena, Forbes, Stuart J., Miska, Eric A., and Huch, Meritxell
- Published
- 2019
- Full Text
- View/download PDF
6. Notch3 drives development and progression of cholangiocarcinoma
- Author
-
Guest, Rachel V., Boulter, Luke, Dwyer, Benjamin J., Kendall, Timothy J., Man, Tak-Yung, Minnis-Lyons, Sarah E., Lu, Wei-Yu, Robson, Andrew J., Gonzalez, Sofia Ferreira, Raven, Alexander, Wojtacha, Davina, Morton, Jennifer P., Komuta, Mina, Roskams, Tania, Wigmore, Stephen J., Sansom, Owen J., and Forbes, Stuart J.
- Published
- 2016
7. Exploring Job Satisfaction and Performance of Staff Nurses in Baguio City, Philippines: A Descriptive Cross-Sectional Study.
- Author
-
Sarmiento, Andrea Dawn N., Rabilas, Jasha Amidala S., Rimada, Raven Alexander M., Rimorin, Kaye Chelsea E., Salangsang, Julius Joseph I., Soriano, Isiah F., Tasani, Bianca Liezel L., Ubando, Rheil Avie A., Uy, Keesha Andrea F., Valdez, Noah Keesha R., Vergara, Christine Joy B., Yabut, Shaira Mae D., and Bandaay, Cheryll M.
- Subjects
NURSES ,PUBLIC hospitals ,CROSS-sectional method ,SCALE analysis (Psychology) ,PROPRIETARY hospitals ,AUTONOMY (Psychology) ,STATISTICAL sampling ,QUESTIONNAIRES ,LEADERSHIP ,WORK environment ,QUANTITATIVE research ,DESCRIPTIVE statistics ,CHI-squared test ,JOB satisfaction ,RESEARCH methodology ,COMMUNICATION ,PROFESSIONAL employee training ,EMPLOYEE reviews ,DATA analysis software ,JOB performance - Abstract
Background: Nursing, as a profession, is a facet where job satisfaction and performance matter. In the changing landscape of nursing practice in the Philippines and the aftermath of the COVID-19 pandemic, it is imperative to revisit and to perform an empirical investigation of the current state of nurses' job satisfaction and performance in the hospital setting. This study aimed to describe the job satisfaction and performance among staff nurses in private and government hospitals in Baguio City. Design: Using a quantitative descriptive cross-sectional survey design, a sample of 313 randomly selected staff nurses working in two private and two government hospitals in Baguio City were surveyed from March to April 2023, using a questionnaire. This study's protocol was approved by two ethics committees, namely the Saint Louis University Research Ethics Committee and the BGHMC REC. Nominal data was analyzed using the SPSS trial version employing frequencies, percentages, and the Chi-square test. Findings: There are more staff nurses in both private and government hospitals who reported satisfactory job satisfaction levels (276 nurses, 87.9%) and had good job performance (303 nurses, 96.5%) in all domains. However, results show that there are more nurses (209 nurses, 90.7% ) in government hospitals who are satisfied with their jobs than in private hospital nurses (67 nurses, 80.1%) in the domains Intra-practice Partnership/Collegiality (p=0.010); Challenge/Autonomy (p=0.001); Professional, Social and Community Interaction (p=0.010); Professional Growth (p=0.036); Time (p=0.009); and Benefits (p=0.045). In terms of job performance, more government nurses at 97.3% (224 nurses) rated a higher self-appraisal of job performance. In comparison, only 94.8% (79 nurses) of private staff nurses appraised themselves as having good performance. No significant differences were found in the domains of job performance, namely leadership, teaching, planning, communications, and professional development, except in critical care. In "Critical care," which showed significance, the results suggest that more nurses in government hospitals perceive higher job performance, revealing a significant difference (p=0.011) in the "critical care" domain, indicating that a higher proportion of nurses in government hospitals demonstrate superior performance in this area. Conclusion: Through this study, it was learned that nurses in both private and government hospitals generally experience high job satisfaction and performance, reflecting a fulfilled workforce and indicating commendable competency among the staff nurses. However, more nurses in government hospitals report high satisfaction and perceived performance in critical care compared to those in private hospitals. Thus, the findings of this study can contribute to and serve as a rationale for policy-making regarding creating a positive work environment, proper management and leadership, creation of training and skill development for critical care, providing opportunities for professional growth, and conducting regular evaluation and feedback----- all geared towards a satisfied and productive workforce. [ABSTRACT FROM AUTHOR]
- Published
- 2024
8. Cholangiocytes act as facultative liver stem cells during impaired hepatocyte regeneration
- Author
-
Raven, Alexander, Lu, Wei-Yu, Man, Tak Yung, Ferreira-Gonzalez, Sofia, O’Duibhir, Eoghan, Dwyer, Benjamin J., Thomson, John P., Meehan, Richard R., Bogorad, Roman, Koteliansky, Victor, Kotelevtsev, Yuri, ffrench-Constant, Charles, Boulter, Luke, and Forbes, Stuart J.
- Published
- 2017
- Full Text
- View/download PDF
9. Lef1 restricts ectopic crypt formation and tumor cell growth in intestinal adenomas
- Author
-
Heino, Sarika, Fang, Shentong, Lähde, Marianne, Högström, Jenny, Nassiri, Sina, Campbell, Andrew, Flanagan, Dustin, Raven, Alexander, Hodder, Michael, Nasreddin, Nadia, Xue, Hai-Hui, Delorenzi, Mauro, Leedham, Simon, Petrova, Tatiana V., Sansom, Owen, Alitalo, Kari, CAN-PRO - Translational Cancer Medicine Program, Digital Precision Cancer Medicine (iCAN), Helsinki Institute of Life Science HiLIFE, HUSLAB, and Kari Alitalo / Principal Investigator
- Subjects
EXPRESSION ,COLON-CANCER ,SciAdv r-articles ,Cell Biology ,MICE LACKING ,BETA-CATENIN ,APC ,RIBOSOMAL DNA ,WNT PATHWAY ,embryonic structures ,C-MYC ,TRANSCRIPTION FACTOR ,3111 Biomedicine ,Biomedicine and Life Sciences ,STEM-CELLS ,Research Article ,Cancer - Abstract
Description, Lef1 is induced in intestinal adenomas, in which it restricts ectopic crypt formation and tumor growth., Somatic mutations in APC or CTNNB1 genes lead to aberrant Wnt signaling and colorectal cancer (CRC) initiation and progression via-catenin–T cell factor/lymphoid enhancer binding factor TCF/LEF transcription factors. We found that Lef1 was expressed exclusively in Apc-mutant, Wnt ligand–independent tumors, but not in ligand-dependent, serrated tumors. To analyze Lef1 function in tumor development, we conditionally deleted Lef1 in intestinal stem cells of Apcfl/fl mice or broadly from the entire intestinal epithelium of Apcfl/fl or ApcMin/+ mice. Loss of Lef1 markedly increased tumor initiation and tumor cell proliferation, reduced the expression of several Wnt antagonists, and increased Myc proto-oncogene expression and formation of ectopic crypts in Apc-mutant adenomas. Our results uncover a previously unknown negative feedback mechanism in CRC, in which ectopic Lef1 expression suppresses intestinal tumorigenesis by restricting adenoma cell dedifferentiation to a crypt-progenitor phenotype and by reducing the formation of cancer stem cell niches.
- Published
- 2021
10. NOTUM from Apc-mutant cells biases clonal competition to initiate cancer
- Author
-
Flanagan, Dustin J, Pentinmikko, Nalle, Luopajärvi, Kalle, Willis, Nicky J, Gilroy, Kathryn, Raven, Alexander P, Mcgarry, Lynn, Englund, Johanna I, Webb, Anna T, Scharaw, Sandra, Nasreddin, Nadia, Hodder, Michael C, Ridgway, Rachel A, Minnee, Emma, Sphyris, Nathalie, Gilchrist, Ella, Najumudeen, Arafath K, Romagnolo, Beatrice, Perret, Christine, Williams, Ann C, Clevers, Hans, Nummela, Pirjo, Lähde, Marianne, Alitalo, Kari, Hietakangas, Ville, Hedley, Ann, Clark, William, Nixon, Colin, Kirschner, Kristina, Jones, E Yvonne, Ristimäki, Ari, Leedham, Simon J, Fish, Paul V, Vincent, Jean-Paul, Katajisto, Pekka, Sansom, Owen J, Flanagan, Dustin J, Pentinmikko, Nalle, Luopajärvi, Kalle, Willis, Nicky J, Gilroy, Kathryn, Raven, Alexander P, Mcgarry, Lynn, Englund, Johanna I, Webb, Anna T, Scharaw, Sandra, Nasreddin, Nadia, Hodder, Michael C, Ridgway, Rachel A, Minnee, Emma, Sphyris, Nathalie, Gilchrist, Ella, Najumudeen, Arafath K, Romagnolo, Beatrice, Perret, Christine, Williams, Ann C, Clevers, Hans, Nummela, Pirjo, Lähde, Marianne, Alitalo, Kari, Hietakangas, Ville, Hedley, Ann, Clark, William, Nixon, Colin, Kirschner, Kristina, Jones, E Yvonne, Ristimäki, Ari, Leedham, Simon J, Fish, Paul V, Vincent, Jean-Paul, Katajisto, Pekka, and Sansom, Owen J
- Abstract
The tumour suppressor APC is the most commonly mutated gene in colorectal cancer. Loss of Apc in intestinal stem cells drives the formation of adenomas in mice via increased WNT signalling1, but reduced secretion of WNT ligands increases the ability of Apc-mutant intestinal stem cells to colonize a crypt (known as fixation)2. Here we investigated how Apc-mutant cells gain a clonal advantage over wild-type counterparts to achieve fixation. We found that Apc-mutant cells are enriched for transcripts that encode several secreted WNT antagonists, with Notum being the most highly expressed. Conditioned medium from Apc-mutant cells suppressed the growth of wild-type organoids in a NOTUM-dependent manner. Furthermore, NOTUM-secreting Apc-mutant clones actively inhibited the proliferation of surrounding wild-type crypt cells and drove their differentiation, thereby outcompeting crypt cells from the niche. Genetic or pharmacological inhibition of NOTUM abrogated the ability of Apc-mutant cells to expand and form intestinal adenomas. We identify NOTUM as a key mediator during the early stages of mutation fixation that can be targeted to restore wild-type cell competitiveness and provide preventative strategies for people at a high risk of developing colorectal cancer.
- Published
- 2021
11. Paracrine cellular senescence exacerbates biliary injury and impairs regeneration
- Author
-
Ferreira-Gonzalez, Sofia, Lu, Wei-yu, Raven, Alexander, Dwyer, Benjamin, Man, Tak Yung, O’Duibhir, Eoghan, Lewis, Philip J. Starkey, Campana, Lara, Kendall, Tim J., Bird, Thomas G., Tarrats, Nuria, Acosta, Juan-Carlos, Boulter, Luke, and Forbes, Stuart J.
- Subjects
Male ,Science ,Liver fibrosis ,Cholangitis, Sclerosing ,Senescence ,Article ,Transforming Growth Factor beta1 ,Mice ,Animals ,Humans ,Regeneration ,Bile ducts ,lcsh:Science ,Myofibroblasts ,Cells, Cultured ,Cellular Senescence ,Keratin-19 ,Mice, Knockout ,Liver Cirrhosis, Biliary ,Macrophages ,Proto-Oncogene Proteins c-mdm2 ,Mice, Inbred C57BL ,Disease Models, Animal ,Mechanisms of disease ,Liver ,Hepatocytes ,lcsh:Q ,Female ,Bile Ducts ,Collagen - Abstract
Cellular senescence is a mechanism that provides an irreversible barrier to cell cycle progression to prevent undesired proliferation. However, under pathological circumstances, senescence can adversely affect organ function, viability and regeneration. We have developed a mouse model of biliary senescence, based on the conditional deletion of Mdm2 in bile ducts under the control of the Krt19 promoter, that exhibits features of biliary disease. Here we report that senescent cholangiocytes induce profound alterations in the cellular and signalling microenvironment, with recruitment of myofibroblasts and macrophages causing collagen deposition, TGFβ production and induction of senescence in surrounding cholangiocytes and hepatocytes. Finally, we study how inhibition of TGFβ-signalling disrupts the transmission of senescence and restores liver function. We identify cellular senescence as a detrimental mechanism in the development of biliary injury. Our results identify TGFβ as a potential therapeutic target to limit senescence-dependent aggravation in human cholangiopathies., Senescence has been suggested as causing biliary cholangiopathies but how this is regulated is unclear. Here, the authors generate a mouse model of biliary senescence by deleting Mdm2 in bile ducts and show that inhibiting TGFβ limits senescence-dependent aggravation of cholangiopathies.
- Published
- 2017
- Full Text
- View/download PDF
12. Corrigendum: Cholangiocytes act as facultative liver stem cells during impaired hepatocyte regeneration
- Author
-
Raven, Alexander, Lu, Wei-Yu, Man, Tak Yung, Ferreira-Gonzalez, Sofia, ODuibhir, Eoghan, Dwyer, Benjamin J., Thomson, John P., Meehan, Richard R., Bogorad, Roman, Koteliansky, Victor, Kotelevtsev, Yuri, ffrench-Constant, Charles, Boulter, Luke, and Forbes, Stuart J.
- Subjects
Environmental issues ,Science and technology ,Zoology and wildlife conservation - Abstract
Author(s): Alexander Raven; Wei-Yu Lu; Tak Yung Man; Sofia Ferreira-Gonzalez; Eoghan ODuibhir; Benjamin J. Dwyer; John P. Thomson; Richard R. Meehan; Roman Bogorad; Victor Koteliansky; Yuri Kotelevtsev; Charles ffrench-Constant; Luke [...]
- Published
- 2018
- Full Text
- View/download PDF
13. Hepatic progenitors in liver regeneration
- Author
-
Raven, Alexander, primary and Forbes, Stuart J., additional
- Published
- 2018
- Full Text
- View/download PDF
14. Basal lamina remodeling at the skeletal muscle stem cell niche mediates stem cell self-renewal
- Author
-
Rayagiri, Shantisree Sandeepani, primary, Ranaldi, Daniele, additional, Raven, Alexander, additional, Mohamad Azhar, Nur Izzah Farhana, additional, Lefebvre, Olivier, additional, Zammit, Peter S, additional, and Borycki, Anne-Gaëlle, additional
- Published
- 2018
- Full Text
- View/download PDF
15. Paracrine cellular senescence exacerbates biliary injury and impairs regeneration
- Author
-
Ferreira-Gonzalez, Sofia, primary, Lu, Wei-Yu, additional, Raven, Alexander, additional, Dwyer, Benjamin, additional, Man, Tak Yung, additional, O’Duibhir, Eoghan, additional, Lewis, Philip J. Starkey, additional, Campana, Lara, additional, Kendall, Tim J., additional, Bird, Thomas G., additional, Tarrats, Nuria, additional, Acosta, Juan-Carlos, additional, Boulter, Luke, additional, and Forbes, Stuart J., additional
- Published
- 2018
- Full Text
- View/download PDF
16. Erratum: Corrigendum: Cholangiocytes act as facultative liver stem cells during impaired hepatocyte regeneration
- Author
-
Raven, Alexander, primary, Lu, Wei-Yu, additional, Man, Tak Yung, additional, Ferreira-Gonzalez, Sofia, additional, O’Duibhir, Eoghan, additional, Dwyer, Benjamin J., additional, Thomson, John P., additional, Meehan, Richard R., additional, Bogorad, Roman, additional, Koteliansky, Victor, additional, Kotelevtsev, Yuri, additional, ffrench-Constant, Charles, additional, Boulter, Luke, additional, and Forbes, Stuart J., additional
- Published
- 2018
- Full Text
- View/download PDF
17. Notch3 drives development and progression of cholangiocarcinoma.
- Author
-
UCL - SSS/IREC-Institut de recherche expérimentale et clinique, UCL - SSS/IREC/GAEN-Pôle d'Hépato-gastro-entérologie, UCL - (SLuc) Service d'anatomie pathologique, Guest, Rachel V, Boulter, Luke, Dwyer, Benjamin J, Kendall, Timothy J, Man, Tak-Yung, Minnis-Lyons, Sarah E, Lu, Wei-Yu, Robson, Andrew J, Gonzalez, Sofia Ferreira, Raven, Alexander, Wojtacha, Davina, Morton, Jennifer P, Komuta, Mina, Roskams, Tania, Wigmore, Stephen J, Sansom, Owen J, Forbes, Stuart J, UCL - SSS/IREC-Institut de recherche expérimentale et clinique, UCL - SSS/IREC/GAEN-Pôle d'Hépato-gastro-entérologie, UCL - (SLuc) Service d'anatomie pathologique, Guest, Rachel V, Boulter, Luke, Dwyer, Benjamin J, Kendall, Timothy J, Man, Tak-Yung, Minnis-Lyons, Sarah E, Lu, Wei-Yu, Robson, Andrew J, Gonzalez, Sofia Ferreira, Raven, Alexander, Wojtacha, Davina, Morton, Jennifer P, Komuta, Mina, Roskams, Tania, Wigmore, Stephen J, Sansom, Owen J, and Forbes, Stuart J
- Abstract
The prognosis of cholangiocarcinoma (CC) is dismal. Notch has been identified as a potential driver; forced exogenous overexpression of Notch1 in hepatocytes results in the formation of biliary tumors. In human disease, however, it is unknown which components of the endogenously signaling pathway are required for tumorigenesis, how these orchestrate cancer, and how they can be targeted for therapy. Here we characterize Notch in human-resected CC, a toxin-driven model in rats, and a transgenic mouse model in which p53 deletion is targeted to biliary epithelia and CC induced using the hepatocarcinogen thioacetamide. We find that across species, the atypical receptor NOTCH3 is differentially overexpressed; it is progressively up-regulated with disease development and promotes tumor cell survival via activation of PI3k-Akt. We use genetic KO studies to show that tumor growth significantly attenuates after Notch3 deletion and demonstrate signaling occurs via a noncanonical pathway independent of the mediator of classical Notch, Recombinant Signal Binding Protein for Immunoglobulin Kappa J Region (RBPJ). These data present an opportunity in this aggressive cancer to selectively target Notch, bypassing toxicities known to be RBPJ dependent.
- Published
- 2016
18. Notch3 drives development and progression of cholangiocarcinoma.
- Author
-
Dwyer, Benjamin J., Tak-Yung Man, Minnis-Lyons, Sarah E., Wei-Yu Lu, Gonzalez, Sofia Ferreira, Raven, Alexander, Wojtacha, Davina, Guest, Rachel V., Boulter, Luke, Forbes, Stuart J., Robson, Andrew J., Wigmore, Stephen J., Kendall, Timothy J., Morton, Jennifer P., Sansom, Owen J., Komuta, Mina, and Roskams, Tania
- Subjects
CHOLANGIOCARCINOMA ,LIVER tumors ,NEOPLASTIC cell transformation ,NOTCH genes ,BILE duct surgery - Abstract
The prognosis of cholangiocarcinoma (CC) is dismal. Notch has been identified as a potential driver; forced exogenous overexpression of Notch1 in hepatocytes results in the formation of biliary tumors. In human disease, however, it is unknown which components of the endogenously signaling pathway are required for tumorigenesis, how these orchestrate cancer, and how they can be targeted for therapy. Here we characterize Notch in human-resected CC, a toxindriven model in rats, and a transgenic mouse model in which p53 deletion is targeted to biliary epithelia and CC induced using the hepatocarcinogen thioacetamide. We find that across species, the atypical receptor NOTCH3 is differentially overexpressed; it is progressively up-regulated with disease development and promotes tumor cell survival via activation of PI3k-Akt. We use genetic KO studies to show that tumor growth significantly attenuates after Notch3 deletion and demonstrate signaling occurs via a noncanonical pathway independent of themediator of classical Notch, Recombinant Signal Binding Protein for Immunoglobulin Kappa J Region (RBPJ). These data present an opportunity in this aggressive cancer to selectively target Notch, bypassing toxicities known to be RBPJ dependent. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
19. Lef1 restricts ectopic crypt formation and tumor cell growth in intestinal adenomas.
- Author
-
Sarika Heino, Shentong Fang, Lähde, Marianne, Högström, Jenny, Nassiri, Sina, Campbell, Andrew, Flanagan, Dustin, Raven, Alexander, Hodder, Michael, Nasreddin, Nadia, Hai-Hui Xue, Delorenzi, Mauro, Leedham, Simon, Petrova, Tatiana V., Sansom, Owen, and Alitalo, Kari
- Subjects
- *
INTESTINES , *TUMOR growth , *WNT signal transduction , *CATENINS , *ADENOMA , *GENETIC mutation , *CELL growth , *STEM cell niches - Abstract
The article presents a study that explores the Lef1 restricts ectopic crypt formation and tumor cell growth in intestinal adenomas. It mentions that how ectopic Lef1 expression suppresses intestinal tumorigenesis by restricting adenoma cell dedifferentiation to a crypt-progenitor phenotype and by reducing the formation of cancer stem cell niches.
- Published
- 2021
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.